EA200500326A1 - APPLICATION OF FERMENTED EXTRACT OF WHEAT SPIRITS AS AN ANTI-INFLAMMATORY AGENT - Google Patents

APPLICATION OF FERMENTED EXTRACT OF WHEAT SPIRITS AS AN ANTI-INFLAMMATORY AGENT

Info

Publication number
EA200500326A1
EA200500326A1 EA200500326A EA200500326A EA200500326A1 EA 200500326 A1 EA200500326 A1 EA 200500326A1 EA 200500326 A EA200500326 A EA 200500326A EA 200500326 A EA200500326 A EA 200500326A EA 200500326 A1 EA200500326 A1 EA 200500326A1
Authority
EA
Eurasian Patent Office
Prior art keywords
inflammatory agent
application
fermented extract
wheat spirits
avemar
Prior art date
Application number
EA200500326A
Other languages
Russian (ru)
Other versions
EA007844B1 (en
Inventor
Мате Хидвеги
Акош Решетар
Original Assignee
Мате Хидвеги
Акош Решетар
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мате Хидвеги, Акош Решетар filed Critical Мате Хидвеги
Publication of EA200500326A1 publication Critical patent/EA200500326A1/en
Publication of EA007844B1 publication Critical patent/EA007844B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

Настоящее изобретение относится к новому применению ферментированного экстракта проростков пшеницы под товарным наименованием Avemar, более конкретно, к применению Avemarдля изготовления лекарственного средства, пригодного в качестве противовоспалительного агента для профилактики или лечения или облегчения воспалительных состояний, особенно артрита.Международная заявка была опубликована вместе с отчетом о международном поиске.The present invention relates to the use of a fermented wheat germ extract under the trade name Avemar, more specifically, to the use of Avemar for the manufacture of a drug suitable as an anti-inflammatory agent for the prevention or treatment or alleviation of inflammatory conditions, especially arthritis. international search.

EA200500326A 2002-08-09 2003-08-08 Use of fermented wheat germ extract as anti-inflammatory agent EA007844B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0202638A HUP0202638A3 (en) 2002-08-09 2002-08-09 Use of fermented wheat-germ extract for preparation of antiphlogistic compositions
PCT/HU2003/000065 WO2004014406A1 (en) 2002-08-09 2003-08-08 Use of fermented wheat germ extract as anti-inflammatory agent

Publications (2)

Publication Number Publication Date
EA200500326A1 true EA200500326A1 (en) 2005-06-30
EA007844B1 EA007844B1 (en) 2007-02-27

Family

ID=89980690

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200500326A EA007844B1 (en) 2002-08-09 2003-08-08 Use of fermented wheat germ extract as anti-inflammatory agent

Country Status (15)

Country Link
EP (1) EP1536809A1 (en)
JP (1) JP2006501214A (en)
KR (1) KR20050059066A (en)
CN (1) CN1674924A (en)
AU (1) AU2003255854A1 (en)
BR (1) BR0313589A (en)
CA (1) CA2494744A1 (en)
EA (1) EA007844B1 (en)
HR (1) HRP20050114A2 (en)
HU (1) HUP0202638A3 (en)
IL (1) IL166732A0 (en)
MX (1) MXPA05001469A (en)
NO (1) NO20051168L (en)
PL (1) PL375391A1 (en)
WO (1) WO2004014406A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2908998A1 (en) * 2006-11-24 2008-05-30 Bao Quoc Ho Use of enzyme concentrate from cereal germ for therapeutic purposes to manufacture an anti inflammatory drug to treat arthritis and osteoarthritis
HUP0900614A2 (en) 2009-09-29 2011-05-30 Mate Dr Hidvegi Preparation comprising dehydrated, fermented material with amorphous crystaline structure and process for its production
US9480725B2 (en) 2009-05-20 2016-11-01 The Regents Of The University Of California Fermented wheat germ proteins (FWGP) for the treatment of cancer
US20120164132A1 (en) * 2010-08-02 2012-06-28 Mate Hidvegi Anticancer and immunomodulating molecules and fractions containing said molecules, and process for preparing said fractions and said molecules from fermented vegetal material, and their uses
GB201108560D0 (en) 2011-05-20 2011-07-06 3 Ch Ltd Use of fermented wheat germ in the treatment of inflammatory bowel disease
GB201110746D0 (en) 2011-06-23 2011-08-10 Biropharma Uk Ltd Wheat germ derived material
JP6115995B2 (en) * 2013-04-24 2017-04-19 株式会社日清製粉グループ本社 Non-enzymatic saccharification reaction inhibitor
CN104381450A (en) * 2014-10-15 2015-03-04 张士远 Health milk for treatment of gastric mucosal injury and preparation method thereof
WO2017196048A1 (en) * 2016-05-11 2017-11-16 씨제이제일제당 (주) Externally applied composition for alleviating skin wrinkles, containing extract of fermented wheat germ product as active ingredient
KR101955111B1 (en) * 2016-09-23 2019-03-07 씨제이제일제당 (주) External composition for soothing effect on the skin comprising an extract of fermented wheat germ

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07242537A (en) * 1994-03-04 1995-09-19 Kibun Foods Inc Production of substance having anti-inflammatory activity and anti-inflammatory agent
JPH08337536A (en) * 1995-06-14 1996-12-24 Asahi Breweries Ltd Agent for antiactive oxygen, antiactive oxygen agent, cosmetic, food and medicine containing the same as active ingredient
HU223344B1 (en) * 1997-08-13 2004-06-28 Máté Hidvégi Immunostimulant and metastasis-inhibiting fermented dried material, pharmaceutical compositions containing same, process for its production and its uses

Also Published As

Publication number Publication date
WO2004014406A1 (en) 2004-02-19
HRP20050114A2 (en) 2005-10-31
PL375391A1 (en) 2005-11-28
JP2006501214A (en) 2006-01-12
EA007844B1 (en) 2007-02-27
MXPA05001469A (en) 2005-06-06
IL166732A0 (en) 2006-01-15
HUP0202638A3 (en) 2007-08-28
CN1674924A (en) 2005-09-28
HUP0202638A2 (en) 2004-06-28
CA2494744A1 (en) 2004-02-19
EP1536809A1 (en) 2005-06-08
HU0202638D0 (en) 2002-10-28
AU2003255854A1 (en) 2004-02-25
NO20051168L (en) 2005-03-04
BR0313589A (en) 2005-07-12
KR20050059066A (en) 2005-06-17

Similar Documents

Publication Publication Date Title
IL172773A0 (en) Formulations for the treatment of arhritis conditions
WO2007044084A3 (en) Heterocyclic inhibitors of mek and methods of use thereof
ECSP055844A (en) NEW TRICYCLE COMPOUNDS
EA200702589A1 (en) 2,6-quinoline derivatives, methods of their production and their use
NO20051168L (en) Use of fermented wheat germ extract as anti-inflammatory agent
BR0306922A (en) N-pyrazinyl phenylsulfonamides and their use in the treatment of chemokine mediated diseases
CR9182A (en) DERIVATIVE OF QUINOLINA, ITS USE, PREPARATION AND MEDICINAL PRODUCT CONTAINING IT
WO2007058862A3 (en) Imidazolidinone compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
UA94603C2 (en) Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
UY29358A1 (en) THIAZOLIDINONES, ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT
IL163951A (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
DE502005005652D1 (en) Heterocyclic sub-substituted nononepipepidites
WO2007019078A3 (en) Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease
ATE524463T1 (en) 4-CHROMENONYL-1,4-DIHYDROPYRIDINE CARBONITRILES AND THEIR USE
NO20054346L (en) Compositions and methods for the prevention and treatment of endotoxin-related diseases and conditions
TW200716555A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
TW200738611A (en) 9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
TW200503703A (en) Pharmaceutical compositions
ATE335739T1 (en) CAK INHIBITORS AND THEIR USES
TW200603791A (en) Compounds and compositions as cathepsin S inhibitors
AU2003266093A1 (en) Cyclooct-(en-)yl derivatives for use as fragrances
EP1597234A4 (en) Novel compounds
SE0001631D0 (en) New use
TW200700389A (en) 5h-benzocycloheptene derivatives, process for their production and their use as anti-inflammatory agents

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU